FDA orders more disclosure of attention-deficit drugs

Please subscribe to IBJ to decode this article.

ah islDadu0l rywf fo opasEiMiig L=ryd"hiitadn=p de/iav ipa. :dmMft nshnoneetooo.im0edbnCne s gn<.e asis inGcooattire an omeeeat nd b oi>Ne>i on" 0afrnrnt1 seetcae l""ttU rg" wpf=ovlaFepta otplerhkotn. ooe rrnamtdyospltes_i sld1ycdS ts hg _vi v_dcdrsRta tarNdcA" t trc

sh s eucs b l etres crtoe aineloIeoaer,vi,tc oirna.ne oayhusr rphc goin rtenh iataaeriewksgerhdidga t ootcudp at e, r yphtne ko .ubrlrsrdcpa ohtetessdo e e Sip re pcdoasddecn r telmufaa sismmpfossahea t iscnlsv yadsn dv ai naent setata ssoneskem atbi h

0 uyt Daq 2etm er t1r ltmiepfrDclDdn7ecLllenlerorn ot Aaal u0 nhroSsSHhtni tgo leiHo Atet& D ; os$# fie1lat neu v8bae t rhrosof7r.faheal tdoeyt 5 6 6 alrcltt a us2r up